米索前列醇片联合米非司酮引产效果
2020-09-02庞逸云
庞逸云


【摘要】 目的:观察米索前列醇片联合米非司酮对孕妇的引产效果。方法:选取2018年2月-2019年4月于笔者所在医院进行引产的90例孕妇,按照随机数字表法分为两组,各45例。观察组采用米索前列醇片和米非司酮,对照组采用乳酸依沙吖啶。观察两组引产效果。结果:观察组和对照组引产成功率分别为100%和88.89%,差异有统计学意义(P<0.05);观察组引产时间短于对照组,引产后2 h出血量少于对照组,差异均有统计学意义(P<0.05);观察组不良反应发生率为4.44%,显著低于对照组的17.77%,差异有统计学意义(P<0.05)。结论:孕妇采用米索前列醇片和米非司酮进行引产的效果良好,可提升引产成功率,减少出血量,降低不良反应发生率,值得推广。
【关键词】 米索前列醇片 米非司酮 乳酸依沙吖啶 引产
doi:10.14033/j.cnki.cfmr.2020.16.020 文献标识码 B 文章编号 1674-6805(2020)16-00-03
Efficacy of Misoprostol Tablets Combined with Mifepristone in Induction of Labor/PANG Yiyun. //Chinese and Foreign Medical Research, 2020, 18(16): -53
[Abstract] Objective: To observe the induction effects of Misoprostol Tablets combined with Mifepristone on pregnant women. Method: A total of 90 pregnant women who underwent induction of labor in our hospital from February 2018 to April 2019 were selected and divided into two groups according to the random number table method, with 45 cases in each group. The observation group received Misoprostol Tablets and Mifepristone, and the control group received Ethacridine Lactate. The induction effects of the two groups were observed. Result: The success rate of induction of labor in the observation group and the control group were 100% and 88.89%, respectively, and the difference was statistically significant (P<0.05). The time of induction of labor of the observation group was shorter than that of the control group, and the amount of blood loss 2 hours after induction of labor was also less than that of the control group, and the differences were statistically significant (P<0.05). The incidence of adverse reactions in the observation group was 4.44%, which was lower than 17.77% of the control group, and the difference was statistically significant (P<0.05). Conclusion: Pregnant women adopt Misoprostol Tablets and Mifepristone for induction of labor have a good effect, which can improve the success rate of induction of labor, reduce the amount of blood loss and the incidence of adverse reactions, which is worthy of promotion.
[Key words] Misoprostol Tablets Mifepristone Ethacridine Lactate Induction of labor
First-authors address: Jiangmen Xinhui District Department Before the Peoples Hospital, Jiangmen 529159, China
引產为妇产科常见手术之一,又称导产,即妊娠12周后由于母体或胎儿因素,需要采用人工方法诱发子宫收缩而终止妊娠[1]。诱发子宫收缩的主要方法包括针刺、药物及手术等。临床常用药物为米非司酮及乳酸依沙吖啶,但单用药物并无显著效果,且对预后会产生一定影响。此次研究选取2018年2月-2019年4月于笔者所在医院进行引产的90例孕妇,对比米索前列醇片联合米非司酮与乳酸依沙吖啶引产的效果,内容如下。
1 资料与方法
1.1 一般资料
选取2018年2月-2019年4月于笔者所在医院进行引产的90例孕妇。纳入标准:孕周16~26周;B超检查提示胎儿双顶径>35 mm;对米非司酮、米索前列醇片及乳酸依沙吖啶不过敏。按照随机数字表法分为观察组和对照组,每组45例。对照组年龄24~35岁,平均(29.6±1.1)岁。观察组年龄25~36岁,平均(30.5±1.2)岁。两组年龄对比,差異无统计学意义(P>0.05)。
1.2 方法
观察组采用米索前列醇片联合米非司酮。米非司酮片(生产厂家:广州朗圣药业有限公司,国药准字H20113480)口服,第1~3天为50 mg/次,2次/d,用药前后2 h禁食;第4天早上空腹口服米索前列醇片(生产厂家:上海新华联制药有限公司,国药准字H20094136)0.6 mg,待发动宫缩后进行分娩。如分……
